Investing News
Market News
Medical Use
Pharmaceutical
The Market Buzz
Regeneron Surpasses Earning Estimates
On Thursday, Regeneron Pharmaceuticals (NASDAQ: REGN) exceeded analysts expectations for quarterly profit. Sales ramped up over 25% and reached USD2.3 Billion, even amid the ongoing coronavirus pandemic. The positive...